Patents by Inventor Elizabeth Ackermann

Elizabeth Ackermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of SLC26A2 expression
    Publication number: 20060154885
    Abstract: Compounds, compositions and methods are provided for modulating the expression of SLC26A2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding SLC26A2. Methods of using these compounds for modulation of SLC26A2 expression and for diagnosis and treatment of disease associated with expression of SLC26A2 are provided.
    Type: Application
    Filed: March 4, 2005
    Publication date: July 13, 2006
    Inventors: C. Bennett, Brett Monia, Nicholas Dean, Xiaoxing Xu, Sanjay Bhanot, Brenda Baker, Susan Freier, Lex Cowsert, Robert McKay, Muthiah Manoharan, F. Dorr, Jon Holmlund, Alexander Borchers, Vickie Brown-Driver, Jacqueline Wyatt, Shin Flournoy, Elizabeth Ackermann, Hong Zhang, Andrew Watt, Eric Maracusson, Scott Cooper, Erich Koller, Loren Miraglia, William Ricketts, Kenneth Dobie, Tamara Sipes
  • Antisense modulation of interleukin 12 P35 subunit expression
    Publication number: 20050261228
    Abstract: Compounds, compositions and methods are provided for modulating the expression of Interleukin 12 p35 subunit. The compositions comprise chemically modified antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Interleukin 12 p35 subunit. Methods of using these compounds for modulation of Interleukin 12 p35 subunit expression and for treatment of diseases associated with expression of Interleukin 12 p35 subunit are provided.
    Type: Application
    Filed: March 23, 2005
    Publication date: November 24, 2005
    Inventors: C. Bennett, Brenda Baker, Susan Freier, Susan Gregory, Ronnie Hanecak, Kevin Anderson, Ming-Yi Chiang, Vickie Brown-Driver, David Ecker, Timothy Vickers, Jacqueline Wyatt, Eric Marcusson, Nicholas Dean, Sanjay Bhanot, Elizabeth Ackermann, Lex Cowsert
  • Antisense modulation of cellular inhibitor of Apoptosis-2 expression
    Publication number: 20050203045
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of Cellular Inhibitor of Apoptosis-2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Cellular Inhibitor of Apoptosis-2. Methods of using these compounds for modulation of Cellular Inhibitor of Apoptosis-2 expression and for treatment of diseases associated with expression of Cellular Inhibitor of Apoptosis-2 are provided.
    Type: Application
    Filed: February 1, 2005
    Publication date: September 15, 2005
    Inventors: C. Bennett, Elizabeth Ackermann, Lex Cowsert
  • Antisense modulation of survivin expression
    Publication number: 20050143335
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.
    Type: Application
    Filed: November 8, 2004
    Publication date: June 30, 2005
    Applicant: ISIS PHARMACEUTICALS, INC.
    Inventors: C. Bennett, Eric Swayze, Elizabeth Ackermann, Lex Cowsert